Sergio Mather
Endocrinology, Diabetes & Metabolism · Fort Myers, FLNPI 1013915024
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 234 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,667 and has fallen 77.6% since, to $373 in 2021. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in FL, where the typical reported total is $3,445.
Across 234 payments — averaging $15.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$549
- Novo Nordisk$531
- AstraZeneca$520
- Lilly USA, LLC$249
- Merck$229
- Amgen$211
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,58199%
- Education$281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 33 | $549 |
| Novo Nordisk | 51 | $531 |
| AstraZeneca | 29 | $520 |
| Lilly USA, LLC | 16 | $249 |
| Merck | 15 | $229 |
| Amgen | 13 | $211 |
| Insulet Corporation | 11 | $193 |
| Boehringer Ingelheim | 9 | $163 |
| Mannkind Corporation | 5 | $96 |
| Valeritas, Inc. | 4 | $65 |
| Antares Pharma, Inc. | 4 | $64 |
| Kowa Pharmaceuticals America, Inc. | 5 | $62 |
| IBSA Pharma Inc. | 4 | $60 |
| Radius Health, Inc. | 3 | $60 |
| Abbott | 3 | $55 |
| Amarin Pharma, Inc. | 3 | $55 |
| Medtronic | 3 | $54 |
| Companion Medical, Inc. | 3 | $49 |
| BD | 2 | $47 |
| Lifescan, Inc. | 2 | $40 |
| Zealand Pharma US, Inc. | 2 | $36 |
| AbbVie | 2 | $32 |
| Actelion Pharmaceuticals US, Inc. | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 2 | $26 |
| Acerus Pharmaceuticals Corporation | 1 | $22 |
| Senseonics, Incorporated | 1 | $20 |
| Recordati_rare_diseases_inc. | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Nevro Corp. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Kvk-tech, Inc. | 1 | $9 |
How this compares
$3,609 in reported general payments places this provider in the 50th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
See all endocrinology, diabetes & metabolism providers in Florida →
Other endocrinology, diabetes & metabolism in Fort Myers
- Jay SkylerMiami$2.2M
- Arelis MaderaPort Charlotte$1.7M
- Damon TantonOrlando$1.2M
- Gaston PonteMelbourne$906K
- Brian LakeLargo$888K
- David SuttonJacksonville$783K
- Mae Sheikh AliJacksonville$751K
- Richard PratleyOrlando$735K
- Lee MetchickDeland$728K
- Misha DenhamCoral Gables$673K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.